News

January 22, 2020

Dystrophin for Genethon and Sarepta Therapeutics Program Goes Into Production

Read More
January 21, 2020

WuXi Biologics and Almirall Collaborate on Dermatology Treatment

Read More
January 20, 2020

Drug Prices Rise in 2020

Read More
January 17, 2020

3D Cell Culture Demand Rises In Latin America

Read More
January 16, 2020

New Insomnia Treatment Approved

Read More
January 15, 2020

DURECT Corporation Announces Results From Phase 2a Clinical Psoriasis Trial

Read More
January 14, 2020

What is Prime Editing?

Read More
January 13, 2020

Yourway Expands Ancillary Sourcing Services

Read More
January 10, 2020

Gene Therapies in Clinical Trials

Read More
January 9, 2020

Allergan Receives FDA Approval for Migraine Treatment

Read More
January 8, 2020

Charles River Laboratories Acquires HemaCare Corporation

Read More
January 7, 2020

BioMarin Pharmaceutical Publishes Follow-Up Data for Hemophilia A Gene Therapy Phase I/II Study

Read More
January 6, 2020

Phase IIa Results Announced for Psoriasis Treatment

Read More
January 3, 2020

Partnership for Sickle Cell Therapy

Read More
January 2, 2020

Cheaper Drugs Through Canada

Read More
January 1, 2020

Artificial Intelligence Expected to Improve R&D

Read More
December 31, 2019

Pharma Ends Year on High Note

Read More
December 30, 2019

The Biosimilars are Coming

Read More
December 27, 2019

Transforming Cells Into Therapies

Read More
December 26, 2019

Cell and Gene Therapy Logistics Trial Complete

Read More
December 25, 2019

Cell and Gene Therapy in Philly

Read More
December 24, 2019

Promising Results for Zika Vaccine Candidate

Read More
December 23, 2019

Matching Clinical Trials to Patients

Read More
December 20, 2019

Publicly Funded Cancer Research is Driving Drug Development

Read More
December 19, 2019

Vistagen's Social Anxiety Disorder Treatment Receives Fast Track Designation

Read More
December 18, 2019

Revised USMCA Pact Reveals New Pharma Provisions

Read More
December 17, 2019

Accelerated Approval Granted for Targeted Duchenne Muscular Dystrophy Treatment

Read More
December 16, 2019

Real-world Performance of Kymriah Matches Clinical Trials

Read More
December 13, 2019

First-In-Human Trial Begins for Novel NHL/MM Immunotherapy

Read More
December 12, 2019

Investigational Drug for Epidermolysis Bullosa Receives Orphan Drug Designation

Read More
Media

Upcoming Event

ISCR conference

January 23-25, 2020
Mumbai, India
Booth #16

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services